Change language
English Deutsch
Change currency
€ EUR £ GBP $ USD
Publicly Available Published by De Gruyter September 2, 2015

Frontmatter

From the journal Drug Metabolism and Personalized Therapy
https://doi.org/10.1515/dmpt-2015-frontmatter3
Download article (PDF)
Published Online: 2015-9-2
Published in Print: 2015-9-1

©2015 by De Gruyter

Download article (PDF)
From the journal
Drug Metabolism and Personalized Therapy
Drug Metabolism and Personalized Therapy
Volume 30 Issue 3
Submit manuscript

Journal and Issue

Articles in the same Issue

Frontmatter
Editorial
Metabolic phenotype prediction from genotyping data: a bottleneck for the implementation of pharmacogenetics in drug development and clinical practice
Reviews in Population Pharmacogenomics
Pharmacogenetics of drug oxidation via cytochrome P450 (CYP) in the populations of Denmark, Faroe Islands and Greenland
Pharmacogenetics of drug metabolizing enzymes in the United Kingdom population: review of current knowledge and comparison with selected European populations
Original Articles
Application of the extended clearance concept classification system (ECCCS) to predict the victim drug-drug interaction potential of statins
Enhancing effect of cimetidine on peroxidase activity of human erythrocyte hemoglobin
Association of ABCB1, ABCC5 and xanthine oxidase genetic polymorphisms with methotrexate adverse reactions in Mexican pediatric patients with ALL
Polymorphisms of CYP1A2 and CYP2A6 activity: phenotypes and the effect of age and sex in a Nigerian population
The D543N polymorphism of the SLC11A1/NRAMP1 gene is associated with treatment failure in male patients with pulmonary tuberculosis
Congress Abstracts
Integration of Pharmacogenomics in clinical decision support
Downloaded on 21.9.2023 from https://www.degruyter.com/document/doi/10.1515/dmpt-2015-frontmatter3/html
Scroll to top button